Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
111.12
+2.53 (2.33%)
At close: Oct 2, 2026, 4:00 PM EDT
111.92
+0.80 (0.72%)
After-hours: Oct 2, 2026, 7:58 PM EDT
Insmed Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $237 → $207 | Buy | Maintains | $237 → $207 | +86.29% | Sep 30, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Reiterates $175 | Buy | Reiterates | $175 | +57.49% | Sep 28, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $218 | Buy | Maintains | $218 | +96.18% | Sep 25, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Initiates $188 | Buy | Initiates | $188 | +69.19% | Sep 24, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $195 | Buy | Maintains | $195 | +75.49% | Sep 23, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $214 | Buy | Maintains | $214 | +92.58% | Sep 22, 2026 |
| Roth MKM | Roth MKM | Buy Reiterates $212 → $198 | Buy | Reiterates | $212 → $198 | +78.19% | Sep 15, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $195 | Buy | Maintains | $195 | +75.49% | Aug 25, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.